PRECERA BIOSCIENCE

Serial Number 87870213
Registration 5822721
700

Registration Progress

Application Filed
Apr 10, 2018
Under Examination
Oct 2, 2018
Approved for Publication
Aug 7, 2018
Published for Opposition
Aug 7, 2018
Registered
Jul 30, 2019

Attorney Assistance

Section 8 Declaration Due (Principal Register) (Based on registration date 20190730) (Grace Period Filing)
Due: Jan 30, 2026 Grace Period - 29 days
Original deadline was Jul 30, 2025 (overdue)

Trademark Image

PRECERA BIOSCIENCE

Basic Information

Serial Number
87870213
Registration Number
5822721
Filing Date
April 10, 2018
Registration Date
July 30, 2019
Published for Opposition
August 7, 2018
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Jul 30, 2019
Registration
Registered
Classes
042

Rights Holder

PHENOMICS HEALTH INC.

03
Address
1600 HURON PKWY, 2ND FLOOR
ANN ARBOR, MI 48109

Ownership History

Sano Informed Prescribing, Inc.

Original Applicant
03
Franklin, TN

Sano Informed Prescribing, Inc.

Owner at Publication
03
Franklin, TN

PRECERA BIOSCIENCE, INC.

New Owner After Publication #1
03
FRANKLIN, TN

PRECERA BIOSCIENCE, INC.

Original Registrant
03
FRANKLIN, TN

PHENOMICS HEALTH INC.

New Owner After Registration #1
03
ANN ARBOR, MI

Legal Representation

Attorney
Steven J. Elleman

USPTO Deadlines

Next Deadline
In Grace Period
Section 8 Declaration Due (Principal Register) (Based on registration date 20190730)
Due Date
July 30, 2025
Grace Period Ends
January 30, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

25 events
Date Code Type Description Documents
Jul 30, 2024 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
Oct 2, 2019 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Oct 2, 2019 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Sep 25, 2019 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Jul 30, 2019 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jun 28, 2019 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Jun 27, 2019 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Jun 12, 2019 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Mar 26, 2019 IUAF S USE AMENDMENT FILED Loading...
Apr 10, 2019 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Mar 26, 2019 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Oct 2, 2018 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Aug 7, 2018 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Aug 7, 2018 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jul 18, 2018 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jul 4, 2018 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
Jun 29, 2018 ALIE A ASSIGNED TO LIE Loading...
Jun 18, 2018 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 14, 2018 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Jun 14, 2018 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Jun 14, 2018 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Jun 14, 2018 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Jun 14, 2018 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 18, 2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 13, 2018 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Scientific and technological services featuring testing, analysis and evaluation of blood samples for the purpose of drug development by others, namely, data-driven analytics and reporting to developers of drugs; scientific and technological services featuring testing, analysis and evaluation of blood samples for the purpose of improving quality in the field of healthcare services, specifically for improving the monitoring and diagnostics of quantitative patient drug exposure, monitoring and diagnostics of patient drug compliance, data-driven analytics and reporting to providers of healthcare services in the field of pharmacovigilance activities, drug dosage recommendations, initial drug prescribing, and drug switching, all for research purposes and not for medical purposes
First Use Anywhere: Mar 25, 2019
First Use in Commerce: Mar 25, 2019

Additional Information

Pseudo Mark
PRECERA BIO SCIENCE

Classification

International Classes
042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"BIOSCIENCE"